- Home
- CRVO vs IDR Comparison
CRVO vs IDR Comparison
Compare CRVO & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- IDR
- Stock Information
- Founded
- CRVO 2001
- IDR 1996
- Country
- CRVO United States
- IDR United States
- Employees
- CRVO N/A
- IDR N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- CRVO Health Care
- IDR Basic Materials
- Exchange
- CRVO Nasdaq
- IDR Nasdaq
- Market Cap
- CRVO 160.4M
- IDR 164.1M
- IPO Year
- CRVO N/A
- IDR N/A
- Fundamental
- Price
- CRVO $10.77
- IDR $11.03
- Analyst Decision
- CRVO Strong Buy
- IDR Strong Buy
- Analyst Count
- CRVO 5
- IDR 1
- Target Price
- CRVO $57.60
- IDR $14.00
- AVG Volume (30 Days)
- CRVO 81.9K
- IDR 328.1K
- Earning Date
- CRVO 11-12-2024
- IDR 11-04-2024
- Dividend Yield
- CRVO N/A
- IDR N/A
- EPS Growth
- CRVO N/A
- IDR 344.27
- EPS
- CRVO N/A
- IDR 0.52
- Revenue
- CRVO $10,066,550.00
- IDR $21,955,008.00
- Revenue This Year
- CRVO $54.67
- IDR $100.42
- Revenue Next Year
- CRVO N/A
- IDR $4.80
- P/E Ratio
- CRVO N/A
- IDR $21.28
- Revenue Growth
- CRVO 116.29
- IDR 64.93
- 52 Week Low
- CRVO $5.85
- IDR $4.84
- 52 Week High
- CRVO $26.38
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- CRVO 33.46
- IDR 30.57
- Support Level
- CRVO $11.95
- IDR $10.72
- Resistance Level
- CRVO $12.35
- IDR $11.83
- Average True Range (ATR)
- CRVO 1.04
- IDR 1.21
- MACD
- CRVO -0.16
- IDR -0.51
- Stochastic Oscillator
- CRVO 7.45
- IDR 4.21
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.